Lantern Pharma Inc.

NasdaqCM:LTRN Stock Report

Market Cap: US$33.9m

Lantern Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:LTRN Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
29 May 25SellUS$168,419Bios Equity Partners LPCompany56,237US$3.05

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of LTRN?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders45,7590.409%
Public Companies631,1955.64%
Private Companies844,1257.55%
VC/PE Firms1,075,9529.62%
Institutions1,260,31911.3%
General Public7,327,07365.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 34.43% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.62%
Bios Equity Partners LP
1,075,952US$3.3m0%2.98%
7.55%
Biological Mimetics, Inc.
844,125US$2.6m0%no data
5.64%
ProPhase Labs, Inc.
631,195US$1.9m0%no data
3.43%
The Vanguard Group, Inc.
384,041US$1.2m5.59%no data
2.01%
CM Management, LLC
225,000US$681.8k12.5%0.53%
0.89%
Renaissance Technologies LLC
100,100US$303.3k10.5%no data
0.82%
Geode Capital Management, LLC
92,081US$279.0k0.21%no data
0.45%
Voss Capital, LP
50,000US$151.5k0%0.01%
0.42%
NewEdge Advisors, LLC
47,279US$143.3k-16.3%no data
0.41%
Donald Keyser
45,759US$138.6k0%no data
0.39%
BlackRock, Inc.
43,090US$130.6k1.93%no data
0.36%
Dimensional Fund Advisors LP
40,144US$121.6k-1.94%no data
0.35%
Susquehanna International Group, LLP
39,094US$118.5k0%no data
0.32%
Westside Investment Management, LLC
35,900US$108.8k0%0.02%
0.3%
UBS Asset Management AG
33,156US$100.5k34.5%no data
0.26%
Horizon Kinetics Holding Corporation
28,791US$87.2k4.38%no data
0.24%
BNY Asset Management
26,481US$80.2k0%no data
0.23%
Davenport & Company LLC
25,814US$78.2k0%no data
0.21%
State Street Global Advisors, Inc.
23,652US$71.7k0%no data
0.16%
Commonwealth Equity Services, LLC
18,161US$55.0k0%no data
0.14%
Two Sigma Investments, LP
16,041US$48.6k0%no data
0.14%
Northern Trust Global Investments
15,589US$47.2k0%no data
0.045%
Group One Trading LLC
5,072US$15.4k70.7%no data
0.019%
SBI Holdings, Inc.
2,143US$6.5k-0.51%no data
0.019%
Allworth Financial, L.P.
2,100US$6.4k2,000%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/01/02 23:49
End of Day Share Price 2026/01/02 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Lantern Pharma Inc. is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Chad MesserLake Street Capital Markets, LLC
Ashok KumarThinkEquity LLC
John VandermostenZacks Small-Cap Research